Merck, Schering-Plough Aim To Be Among Top-Five Players In Emerging Markets
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Merck expects to bring more than $2 billion in annual revenue from emerging markets and to meet its goal of reaching the top-five market share in targeted emerging markets following its merger with Schering-Plough